BOK Financial’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.27M Buy
7,892
+143
+2% +$41.1K 0.04% 328
2025
Q1
$2.39M Buy
7,749
+2,161
+39% +$666K 0.04% 310
2024
Q4
$2.04M Sell
5,588
-21
-0.4% -$7.66K 0.03% 329
2024
Q3
$1.96M Buy
5,609
+29
+0.5% +$10.2K 0.03% 338
2024
Q2
$1.78M Buy
+5,580
New +$1.78M 0.03% 378
2023
Q2
Sell
-7
Closed -$1.57K 1180
2023
Q1
$1.57K Sell
7
-4,445
-100% -$996K ﹤0.01% 1118
2022
Q4
$1.24M Buy
4,452
+105
+2% +$29.2K 0.02% 461
2022
Q3
$910K Buy
4,347
+162
+4% +$33.9K 0.02% 521
2022
Q2
$986K Sell
4,185
-48
-1% -$11.3K 0.02% 523
2022
Q1
$759K Buy
+4,233
New +$759K 0.01% 648
2019
Q3
Sell
-16,266
Closed -$1.27M 951
2019
Q2
$1.27M Sell
16,266
-3,119
-16% -$244K 0.03% 436
2019
Q1
$2.28M Sell
19,385
-14
-0.1% -$1.64K 0.05% 324
2018
Q4
$2.11M Sell
19,399
-562
-3% -$61.2K 0.06% 310
2018
Q3
$2.55M Sell
19,961
-233
-1% -$29.8K 0.06% 321
2018
Q2
$2.29M Sell
20,194
-401
-2% -$45.4K 0.06% 328
2018
Q1
$2.31M Buy
20,595
+181
+0.9% +$20.3K 0.07% 320
2017
Q4
$3.02M Sell
20,414
-246
-1% -$36.4K 0.08% 274
2017
Q3
$2.42M Sell
20,660
-9,649
-32% -$1.13M 0.07% 303
2017
Q2
$3.93M Sell
30,309
-1,393
-4% -$181K 0.12% 190
2017
Q1
$4.29M Buy
31,702
+333
+1% +$45.1K 0.13% 178
2016
Q4
$4.5M Sell
31,369
-540
-2% -$77.4K 0.15% 155
2016
Q3
$3.77M Sell
31,909
-4,136
-11% -$488K 0.12% 190
2016
Q2
$3.82M Buy
36,045
+757
+2% +$80.2K 0.13% 163
2016
Q1
$3.93M Buy
35,288
+933
+3% +$104K 0.14% 171
2015
Q4
$5.38M Buy
+34,355
New +$5.38M 0.19% 127
2014
Q1
Sell
-2,089
Closed -$236K 899
2013
Q4
$236K Sell
2,089
-23,324
-92% -$2.63M 0.01% 800
2013
Q3
$2M Buy
+25,413
New +$2M 0.07% 288